PE/TR Anti-Human CD38 Antibody[HIT2]

The PE/TR Anti-Human CD38 Antibody [HIT2] is a highly specialized and meticulously crafted product designed to facilitate accurate and efficient detection of CD38 expression in human samples. This antibody, developed with utmost precision, exhibits exceptional specificity and sensitivity, making it an invaluable tool for researchers and clinicians alike.

The PE/TR Anti-Human CD38 Antibody [HIT2] is meticulously manufactured using cutting-edge technology and stringent quality control measures to ensure optimal performance and reliability. It is conjugated with two fluorochromes, PE and TR, enabling simultaneous detection of CD38 expression in a multiparametric flow cytometry setting.

This antibody demonstrates remarkable affinity towards CD38, a transmembrane glycoprotein expressed on various cell types, including lymphocytes, monocytes, and plasma cells. Its exceptional specificity ensures minimal cross-reactivity with other antigens, thereby enhancing the accuracy and reliability of experimental results.

The PE/TR Anti-Human CD38 Antibody [HIT2] offers unparalleled sensitivity, enabling the detection of even low levels of CD38 expression. This attribute is particularly advantageous in research and clinical settings where precise quantification of CD38 expression is crucial for disease diagnosis, prognosis, and monitoring.

Furthermore, this antibody's compatibility with multiparametric flow cytometry allows for simultaneous analysis of multiple markers, facilitating comprehensive and detailed characterization of cell populations. Its exceptional performance and versatility make it an indispensable tool for immunophenotyping studies and immunomonitoring applications.

In summary, the PE/TR Anti-Human CD38 Antibody [HIT2] is a meticulously developed and rigorously tested product that offers exceptional specificity, sensitivity, and versatility. Its utilization in research and clinical settings promises to enhance the accuracy and efficiency of CD38 expression analysis, ultimately contributing to advancements in disease diagnosis, prognosis, and therapeutic monitoring.